BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock?

BridgeBio Pharma (BBIO) shares ended the last trading session 17.1% higher at $63.56. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 8.4% gain over the past four weeks.The stock rallied after the company announced positive top-line data from the pivotal phase III FORTIFY study evaluating BBP-418 in people living with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). The study achieved all primary and secondar ...